Evolution of Targeted Sequencing: What’s Coming up Next?
In recent years, targeted sequencing has dramatically transformed the way we understand and approach genomics. From identifying specific genetic variants to guiding precision medicine, targeted sequencing has become a crucial tool in biology and medicine. With new technologies and innovations emerging on the horizon, the future of targeted sequencing looks more exciting than ever.
This blog will explore the latest developments in targeted sequencing and what we can expect to see in the coming years. From new applications to enhanced accuracy and efficiency, it will delve into what’s next for this rapidly evolving field.
What is targeted sequencing?
Targeted sequencing is a powerful tool for genomic analysis that allows for the selective amplification and sequencing of specific regions of interest within the genome. Unlike whole genome sequencing, which sequences all of the deoxyribonucleic acid (DNA) within an organism, targeted sequencing focuses on specific regions that are most relevant for a particular study or research question.
This approach provides a cost-effective and efficient alternative to whole genome sequencing and can be used to identify specific genetic variations or mutations within a population.
Targeted sequencing is commonly used in various applications, including medical diagnosis, cancer research, and population genetics. In the medical field, targeted sequencing is used to diagnose genetic disorders, evaluate the risk of disease, and guide precision medicine by identifying specific genetic variants that may contribute to the disease.
According to the BIS Research report, the global targeted sequencing market is projected to reach $10.97 billion by 2032 from $3.19 billion in 2022, growing at a CAGR of 13.12% during the forecast period 2022–2032.
To get more information, download this FREE sample report.
In cancer research, targeted sequencing is used to study the genetic changes that occur in tumor cells, which can inform the development of new treatment strategies. In population genetics, targeted sequencing can be used to study genetic variation within populations, including differences in disease susceptibility, drug metabolism, and evolutionary history.
How has targeted sequencing evolved since the beginning?
The evolution of targeted sequencing has been marked by significant advancements in technology, increasing accuracy and speed, and reduced costs. This evolution can be divided into three main generations, each with its own unique characteristics and capabilities:
First-Generation Targeted Sequencing
The first generation of targeted sequencing was characterized by the use of restriction enzymes to cleave genomic DNA and linkers to amplify specific regions of interest. This method, known as restriction site-associated DNA sequencing (RAD-seq), was relatively fast and cost-effective but suffered from limitations in accuracy and resolution.
Second-Generation Targeted Sequencing
Second-generation targeted sequencing marked a major advancement in the field with the introduction of high-throughput sequencing platforms, such as Illumina and Roche 454, which allowed for the simultaneous sequencing of millions of DNA fragments. This increased the accuracy and resolution of targeted sequencing and opened the door for large-scale genomic studies.
Third-Generation Targeted Sequencing
The third generation of targeted sequencing represents the most recent advancements in the field, including the use of long-read sequencing technologies, such as Oxford Nanopore and PacBio, which allow for the accurate sequencing of complex genomic regions and the resolution of structural variants. This has opened up new avenues for research in areas such as cancer genomics, where the ability to study large structural variants is critical.
Additionally, third-generation sequencing technologies have enabled the development of new methods for capturing specific regions of interest, such as single-cell sequencing, which allows for the analysis of individual cells within a tissue sample.
What is the growth potential and future of targeted sequencing?
The continued advancement of sequencing technologies, combined with the growing demand for more efficient and effective ways to study the genome, make targeted sequencing a critical tool in the field of genomics. Here are a few key areas where targeted sequencing is expected to play a significant role in the future:
Precision Medicine: Targeted sequencing will play an increasingly important role in the development of precision medicine, helping to identify specific genetic variations that contribute to disease and inform the development of personalized treatments.
Cancer Research: Targeted sequencing will continue to be a critical tool for cancer research, allowing scientists to study the genomic changes that occur in tumor cells and inform the development of new treatments and therapies.
Agricultural Biotechnology: Targeted sequencing will be increasingly used to study the genomes of crop and livestock species, which can inform the development of new breeding programs and improve the sustainability of agricultural production.
Environmental Genomics: Targeted sequencing will also play a key role in environmental genomics, allowing scientists to study the genomes of non-model species and understand the impact of environmental changes on biodiversity.
New Technologies: The development of new sequencing technologies, such as single-cell sequencing, is expected to drive the growth of targeted sequencing in the future, allowing researchers to study the genomic changes that occur in individual cells and better understand complex biological processes.
The future of targeted sequencing is bright and full of potential as new advancements and innovations arise. As sequencing technologies continue to improve, targeted sequencing will become increasingly crucial in shaping our knowledge of genomes and assisting in the creation of novel treatments and therapies.
Conclusion
Targeted sequencing has come a long way since its inception, and it continues to evolve and impact various fields of science and medicine. The ability to study specific regions of interest within the genome has provided new insights into the biology of cells and organisms and has the potential to inform the development of new treatments and therapies.
Moreover, with each new generation of technology, researchers are able to gain a deeper understanding of the genome and the underlying mechanisms of disease.
Interested to know more about the developing technologies in your industry vertical? Get the latest market studies and insights from BIS Research. Connect with us at hello@bisresearch.com to learn and understand more.
